InjuryBoard Galveston Bay Archives

• Birth Defects Attributed to CellCept

  Scott Kappes | October 30, 2007 1:41 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Yesterday the FDA announced warning label changes for anti-rejection medication, CellCept, used after organ transplants. The new boxed warning claims that the drug may pose a significant risk to pregnant women. The drug can be associated with an increased risk of pregnancy loss within the first trimester and increased risk of abnormalities and birth defects. The FDA warns of many possible...

• Provigil Gets Additional Warnings

  Scott Kappes | October 25, 2007 4:32 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Yesterday the FDA announced that it would be adding a new warning to Cephalon Inc.'s excessive sleepiness and narcolepsy medication, Provigil, for risk of developing a serious skin rash and psychiatric symptoms. This is the second FDA warning for a Cephalon drug in as many months. Last month "Dear Doctor" letters were sent out regarding the powerful painkiller, Fentora, and its link to four...

• Byetta Cited by FDA for Pancreatitis Risk

  Scott Kappes | October 22, 2007 2:53 PM | 0 Comments
  Category: FDA & Prescription Drugs

  The popular type-2 diabetes medication, Byetta, has been linked to acute pancreatitis after a review of 30 postmarketing reports. The FDA suspects an association between Byetta and acute pancreatitis, and has recommended labeling changes to warn patients and physicians of the possible danger. Manufacturer, Amylin Pharmaceuticals, Inc. has agreed to include the proposed changes regarding acute...

• Class I Recall Issued For Defibrillator Leads

  Scott Kappes | October 18, 2007 2:41 PM | 0 Comments
  Category: Defective & Dangerous Products

  The FDA has issued a Class I Recall for possible fracture risks of Medtronic Defibrillator Leads. The recall comes one day after the company issued a warning of possible fracture dangers and voluntarily stopped distribution of suspected products. The FDA says that fracture risks can be associated with a very small percentage of manufactured leads however they are taking fast and furious action....

• Zyprexa Gets Stronger Warnings

  Scott Kappes | October 09, 2007 1:08 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Last Friday Eli Lilly and Co. announced that they will be pumping up the warnings on the anti-psychotic drug Zyprexa. Zyprexa is used to treat schizophrenia and bipolar disorder. The drug has been seen to induce weight gain, increase blood sugar levels and cholesterol among other concerns. The new warnings will give a more accurate representation of these potential risks associated with the use...

• Doctors to be Warned About Imaging Agent Risks

  Scott Kappes | October 08, 2007 5:37 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Today it was announced that the FDA will be issuing warnings to doctors about the risks associated with certain imaging agents used to better view the heart in an echocardiograph. The FDA has been investigating reports of serious cardiopulmonary reactions and even deaths associated with the imaging agents. The agents in question are manufactured by Bristol-Myers Squibb Co. under the name...

• Cymbalta Promotion Halted by FDA

  Scott Kappes | October 04, 2007 12:56 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Eli Lilly and Co., the manufacturer of the fast-selling dug Cymbalta has been issued a letter by the FDA ordering them to immediately stop promoting the drug. The FDA claims that a mailer sent out by the company greatly overstates the effectiveness of Cymbalta and conveniently leave out the most serious risks associated with using the drug. Eli Lilly was asked to "immediately cease"...

• Have You Had an Adverse Reaction to Chantix?

  Scott Kappes | October 03, 2007 3:27 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Over the past month since the Carter Albrecht story hit the press there has been plenty of attention paid to the stop smoking aid Chantix. I am sure that most of it is not the kind of publicity that manufacturer Pfizer was hoping for as they launched their new add campaign. Our law office has been contacted by numerous people over the past month with claims of serious adverse reactions to...

• Thousands of Prescription Drugs are NOT Approved by FDA

  Scott Kappes | October 02, 2007 12:53 PM | 0 Comments
  Category: FDA & Prescription Drugs

  I recently read a USA Today article about unapproved drugs on the U.S. market and I was completely blown away by what I found out from it. It turns out that thousands of the drugs that doctors write prescriptions for each day are not approved for sale by the FDA. With all of the controversy and allegations surrounding FDA approved drugs like the recent troubles of Avandia and the colossal...

• "Black Box" warning for Gadolinium Agents

  Scott Kappes | October 01, 2007 11:54 AM | 0 Comments
  Category: FDA & Prescription Drugs

  Last Friday the FDA completed the decision made a few months back to add a "black box" warning to all FDA approved gadolinium containing contrast agents, by issuing a "Dear Healthcare Professional" letter. These contrast agents are commonly used in conjunction with magnetic resonance imaging (MRI) to greatly enhance the image produced by the procedure. These contrast agents however have been...